ClinicalTrials.gg
RecruitingNCT07899606Updated Oct 27, 2026

Digital Eye®-Assisted Bone Density Classification and Primary Dental Implant Stability.

An interventional study of R2GATE Digital EYE-Assisted Site-Specific Drilling Protocol and R2GATE® Digital EYE® Implant Planning Software in Bone Mineral Density, Primary Implant Stability and Digital Eye Bone Density Assessment, sponsored by King Abdullah University Hospital. Recruiting at 1 site in Jordan. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-27.

Sponsored by King Abdullah University Hospital · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 1 year 6 months after the study started (first participant enrolled Apr 2025, registered Oct 2026).
  • Started Apr 2025; still recruiting 1 year 7 months later.
Updated Oct 27, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Dental implants are used nowadays to replace extracted teeth. They provide a successful substitute for lost teeth. Accurate planning prior to implant placement is very important. Reduced bone density at the site of dental implant placement can affect the success of dental implants. Thus, accurate evaluation of the density is an important aspect in planning. This prospective, single-arm clinical study investigate the clinical applicability of site-specific bone-density assessment and software-recommended drilling in relation to primary implant stability in adults requiring a single implant in a healed premolar or molar site.

Read the detailed description

Primary stability is the mechanical fixation of a dental implant in the surrounding bone immediately after placement. It is influenced by several factors, including local bone characteristics, implant design, and the preparation of the implant site. Conventional bone classification systems describe bone quality broadly and may not fully represent variations in bone characteristics within the specific area intended to receive an implant. An assessment that focuses more closely on the planned implant site may therefore provide additional information for individualized surgical planning.

The R2GATE® Digital EYE® feature provides a color-coded representation of bone characteristics on cone-beam computed tomography (CBCT) images. In this study, a site-specific classification was developed based on the distribution of the software-generated colors in the bone surrounding the virtually planned implant. This classification was used to guide the application of the software-recommended drilling protocol. The recommended drilling sequence may be fully mandatory or may include an optional final drill, allowing the protocol to account for the software recommendation and the clinical drilling sequence used during surgery.

The digital workflow integrates CBCT data with digital intraoral scans to create a three-dimensional model for prosthetically guided implant planning. The planned implant position is assessed in relation to the intended restoration and relevant anatomical structures, and a surgical guide is designed to transfer the digital plan to the clinical setting. The R2GATE® Digital EYE® software is used to assess bone density at the planned implant site and generate a site-specific drilling protocol. Primary implant stability is measured immediately after placement using insertion torque and resonance frequency analysis, reported as the implant stability quotient (ISQ).

The study aims to investigate the clinical applicability of site-specific bone-density assessment and software-recommended drilling in relation to primary implant stability and implant placement accuracy. There is no randomized comparison group. The study also assesses the agreement between bone-density classifications generated by R2GATE® and ACTEON® Imaging Suite, examines the relationship between implant diameter and primary stability, and evaluates the accuracy of implant depth transfer from digital planning to surgery using sleeved and sleeveless surgical guides.

The findings may help inform future research into individualized implant site preparation. The proposed classification and software-recommended drilling approach should not be considered independently validated, and the study does not establish their effects on long-term implant survival or success.

02

Conditions studied

  • Bone Mineral Density
  • Primary Implant Stability
  • Digital Eye Bone Density Assessment
  • Site-specific Drilling Protocol

Keywords

  • Bone Mineral Density
  • Dental implants
  • Validity
  • Cone Beam CT
  • Primary implant stability
  • Insertion torque
  • Resonance frequency analysis
  • Computer-guided implant surgery
  • ISQ
  • Site-specific drilling protocol
  • R2GATE
  • Digital Eye
03

In context

Lead sponsor

King Abdullah University Hospital is the lead sponsor of 55 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Patient recruitment was based on the following inclusion and exclusion criteria:

Inclusion Criteria

Patients were included if they met the following criteria:

  1. Age ≥18 years.
  2. Absence of systemic conditions contraindicating implant surgery.
  3. Non-smokers or light smokers (less than 10 Cig/Day).
  4. healthy and stable periodontal tissues.
  5. Having a single tooth bounded edentulous area.
  6. Availability of sufficient bone height and width to allow implant placement without the need for simultaneous or staged bone augmentation procedures as evaluated on CBCT
  7. Provision of written . Exclusion Criteria

Patients were excluded if any of the following conditions were present:

  1. Local or systemic infection at the time of implant placement.
  2. Metabolic or osseous diseases affecting bone metabolism, including osteoporosis and osteopetrosis.
  3. Renal disease, oncologic disease, or disorders affecting calcium metabolism.
  4. Benign or malignant pathology involving the maxillary or mandibular bones.
  5. Previous implant or prosthetic treatment at the study site.
  6. Previous or current bisphosphonate therapy.
  7. History of head and neck radiotherapy.
  8. Multiple tooth or unbounded edentulous area.
  9. Requirement for bone augmentation before or during implant placement.
  10. Periodontitis patients.
  11. Age \<18 years.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    R2GATE Digital EYE-Guided Implant Placement

    All participants undergo digitally guided dental implant placement using a site-specific drilling protocol based on bone-density assessment with R2GATE® Digital EYE®. The software generates a recommended drilling sequence for the planned implant site. The final drill is recorded. Primary implant stability is measured immediately after placement using insertion torque and resonance frequency analysis, reported as the implant stability quotient (ISQ). Implant placement is performed using a digitally planned surgical guide.

    Procedure: R2GATE Digital EYE-Assisted Site-Specific Drilling Protocol · Device: R2GATE® Digital EYE® Implant Planning Software · Device: MEGA ISQ® - Implant Stability Measurement Device · Device: Insertion Torque Measurement · Device: UNC-15 Probe Depth Measurement Device

Interventions

  • ProcedureR2GATE Digital EYE-Assisted Site-Specific Drilling Protocol

    Digitally guided implant placement will be planned and performed for thirty bounded edentulous maxillary and thirty mandibular molar healed sites. Pre-operative CBCT Images of the maxillary and mandibular jaws of the recruited patients will be acquired. Images will be obtained in DICOM format and exported to the software for pre-operative digital implant planning. R2GATE® Digital EYE® is used to assess bone density at the planned implant site and generate a site-specific drilling recommendation. The osteotomy is prepared according to the software-recommended drilling sequence, with the use or omission of an optional final drill recorded when applicable. Primary implant stability is measured immediately after placement using insertion torque and resonance frequency analysis, reported as the implant stability quotient (ISQ). A digitally designed surgical guide is used to guide placement of a MegaGen AnyRidge® dental implant.

  • DeviceR2GATE® Digital EYE® Implant Planning Software

    R2GATE® Digital EYE® software is used to assess bone density at the planned implant site and generate a site-specific drilling recommendation. Preoperative CBCT images are imported into the software for digital implant planning. The recommended osteotomy drilling sequence is followed during implant placement.

  • DeviceMEGA ISQ® - Implant Stability Measurement Device

    The MEGA ISQ® device is used to assess primary dental implant stability immediately after implant placement using resonance frequency analysis (RFA). Measurements are recorded as implant stability quotient (ISQ) values in the specified measurement directions, and the readings are averaged to obtain the mean ISQ for each implant.

  • DeviceInsertion Torque Measurement

    A dental implant surgical motor (MEG Engine® II ) with torque measurement is used during implant placement to record insertion torque, expressed in N·cm, as an indicator of primary implant stability. The insertion torque value is recorded for each implant immediately after placement.

  • DeviceUNC-15 Probe Depth Measurement Device

    The UNC-15 Probe is used to assess the clinically achieved implant placement depth. The measured clinical depth is recorded and compared with the digitally planned implant depth to evaluate the accuracy of implant placement and the discrepancy between planned and achieved depths.

06

What researchers measure

Primary outcomes

  1. Resulted Insertion torque according to R2GATE Digital EYE bone-density classification and its site specific drilling protocol.

    Insertion torque is the maximum torque recorded by the implant motor during implant insertion, expressed in Ncm. Values will be summarized and evaluated in relation to the R2GATE® Digital EYE® site-specific bone-density categories and the software-recommended drilling protocol and clinical drilling sequence.

    Time frame: At the time of final implant seating, when the implant reached its planned position (postoperative)

  2. Mean implant stability quotient (ISQ) according to R2GATE Digital EYE bone-density classification and its site specific drilling protocol.

    Primary implant stability is assessed using resonance frequency analysis (RFA). Five directional ISQ readings are obtained for each implant from the mesial, distal, occlusal, lingual/palatal, and buccal directions. The mean of these five readings is calculated for each implant and evaluated in relation to the R2GATE® Digital EYE® site-specific bone-density categories and the software-recommended drilling protocol and clinical drilling sequence.

    Time frame: Immediately after implant placement , when the implant reached its planned position (postoperative)

Secondary outcomes

  1. Agreement between R2GATE Digital EYE and ACTEON Imaging Suite bone-density classifications

    Agreement between the site-specific bone-density classifications obtained using R2GATE® Digital EYE® and ACTEON® Imaging Suite will be assessed using the percentage of exact agreement and linearly weighted Cohen's kappa with a 95% confidence interval.

    Time frame: During preoperative digital implant planning, before implant placement.

  2. Assessment of the primary stability according to implant diameter (4.0 mm versus 4.5 mm)

    Insertion torque, expressed in Ncm, and mean ISQ, calculated from five directional resonance frequency measurements per implant, will be compared between implants with diameters of 4.0 mm and 4.5 mm.

    Time frame: At final implant seating and immediately after implant placement (postoperative)

  3. Implant placement depth accuracy with sleeved and sleeveless surgical guides

    The absolute difference, in millimeters, between the digitally planned and clinically achieved crest-to-implant-platform distances will be calculated at the mid-buccal and mid-lingual/palatal aspects. Absolute depth deviations will be compared between implants placed using sleeved and sleeveless surgical guides.

    Time frame: At the preoperative digital plan and clinical measurements recorded immediately after placement at final implant seating (postoperative).

  4. Agreement between digitally planned and clinically achieved implant depth

    The discrepancy between the clinically achieved and digitally planned crest-to-implant-platform distances will be assessed in millimeters at the mid-buccal and mid-lingual/palatal aspects. Agreement will be evaluated using the mean bias and 95% limits of agreement from Bland-Altman analysis, with paired comparisons of planned and achieved measurements.

    Time frame: At implant placement, comparing the preoperative digital plan with clinical measurements recorded immediately after placement (postoperative).

  5. Correlation between insertion torque and mean implant stability quotient

    The association between insertion torque, expressed in Ncm, and mean ISQ, calculated from five directional resonance frequency measurements per implant, will be assessed using Spearman's rank correlation coefficient.

    Time frame: During implant placement and immediately after placement, when insertion torque and ISQ measurements are obtained, respectively when the implant reached its planned position (postoperative).

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — There is currently no plan to make individual participant data (IPD), including data dictionaries, available to other researchers. Participant confidentiality and the ethical requirements governing the use of clinical and radiographic data will be maintained. Study findings will be reported in scientific publications.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 27, 2026
Show all 1 update
  1. Oct 27, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07899606
Lead sponsor
King Abdullah University Hospital
Responsible party
Reem Abdel-Hafez (Associate Professor of Periodontology, King Abdullah University Hospital) — Principal investigator
First posted
Oct 27, 2026
Start date
Apr 1, 2025
Primary completion
Jan 30, 2027 (estimated)
Completion
Jan 30, 2027 (estimated)
Last update
Oct 27, 2026

Study contacts

Reem Sami Abdel-Hafez, A. Prof of Periodontology
Contact
rsabdelhafez@just.edu.jo
00962799497779
Hana Abdulmouin Rahhal, MClinDent in Periodontology
Contact
harahhal23@den.just.edu.jo
00962795662361
Reem Sami Abdel-Hafez
study chair · Jordan University of Science and Technology

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion